Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II pilot study of SLITonePLUS Birch via sublingual vs vestibular administration
2009-014580-39Phase 2Completed
- Sponsor
- ALK-Abelló
- Start
- Oct 2009
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of birch pollen allergen extract in Birch Pollen Allergic Rhinitis (BPAR) (2 arms), sponsored by ALK-Abelló. Started Oct 2009; status: completed.
02
Drugs
birch pollen allergen extract
03
Conditions
Birch Pollen Allergic Rhinitis (BPAR)
Beyond the preview
Go deeper on 2009-014580-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014580-39.